# Ambrosia: Evaluating the Effects of a Food-As-Medicine Platform on Gut Microbiome Composition and Metabolism

> **NCT06091813** · NA · COMPLETED · sponsor: **Persephone Biosciences** · enrollment: 546 (actual)

## Conditions studied

- Impact of Dietary Chages Directed by Medical Nutrition Therapy on Gut Microbiome Composition

## Interventions

- **BEHAVIORAL:** Nutrition Counseling

## Key facts

- **NCT ID:** NCT06091813
- **Lead sponsor:** Persephone Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2025-03-15
- **Final completion:** 2025-03-15
- **Target enrollment:** 546 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06091813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06091813, "Ambrosia: Evaluating the Effects of a Food-As-Medicine Platform on Gut Microbiome Composition and Metabolism". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06091813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*